Cheju Halla General Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT02027311
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Cheju Halla General Hospital, Doreongno 65, Jeju-si Jeju Special Self-Governing Province, Korea 690-766

Active Ingredients

Drugs in Phase 4 Trials (3)

etomidate (amidate) (1 trial)

meperidine (demerol) (1 trial)

midazolam (versed) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cholangiocarcinoma (Phase 4)

Choledocholithiasis (Phase 4)

Pancreatitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3